Stay updated on Nivolumab in Salivary Gland Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Salivary Gland Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record for the NISCAHN phase II trial of nivolumab in recurrent or metastatic salivary gland carcinoma is displayed, with details about the study design, participants, locations, and measured outcomes.
    Difference
    52%
    Check dated 2026-11-08T12:55:32.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the study record remains inaccessible with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-01T13:17:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH notice says federal agencies are transitioning to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), and that both terms may appear during the transition.
    Difference
    1%
    Check dated 2026-10-25T13:23:22.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:27:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:11:07.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Access to the study record now shows a 403 Forbidden error page with the site header and footer. This blocks display of the study details and navigation that would normally appear on the record page.
    Difference
    18%
    Check dated 2026-09-20T19:53:55.000Z thumbnail image

Stay in the know with updates to Nivolumab in Salivary Gland Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.